Biotron

Contact
biotron.com.au
+61-293003344

Biotron Limited

Level 2 66 Hunter Street
NSW 2000 Sydney
Australia
+61-293003344
biotron.com.au
Contact
Profile News
Contact

About Biotron

Biotron Limited is engaged in the research, development, and commercialisation of drugs targeting significant viral diseases with unmet medical need, with a major focus on HIV and HCV. The Company has BIT225 in clinical development for both HIV and HCV, and also has several earlier stage preclinical and research programs for several other viral infections including influenza, Dengue and Hepatitis B.

Read more about Biotron
Facts about Biotron
  • Industry : Pharma

News about Biotron

Biotron

21-Dec-2012 | research and development

Biotron completes clinical stage of HIV clinical trial

Biotron Limited (BIT) has completed the clinical stage of a landmark phase 1b/2a proof-of-concept human trial of its lead HIV drug candidate, BIT225. The pl ...

Read news
Biotron

12-Oct-2011 | research and development

Positive results for Biotron Hepatitis C pPhase 2a trial

Biotron Limited  has headline results from its Phase 2a trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients.  Preliminary ...

Read news
Biotron

14-Mar-2011 | research and development

Stage one of Biotron's Hepatitis C drug trial completed

Biotron Limited has completed stage one of a human trial of its lead Hepatitis C drug candidate, BIT225.  Twelve patients have been dosed in the first half ...

Read news
Biotron

18-Dec-2009 | research and development

Biotron progresses HIV treatment

Biotron Limited announced that anti-viral drug BIT225 is able to stop HIV spreading. The drug was tested in a study involving 18 HIV positive patients at ...

Read news
Show more news about Biotron

Here you will find Biotron Limited